Loading clinical trials...
Loading clinical trials...
A Long-term Multicenter Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extra-pulmonary Involvement
Conditions
Interventions
XTMAB-16
Locations
11
United States
Xentria Investigative Site
Denver, Colorado, United States
Xentria Investigative Site
Chicago, Illinois, United States
Xentria Investigative Site
Greenville, North Carolina, United States
Xentria Investigative Site
Cincinnati, Ohio, United States
Xentria Investigative Site
Philadelphia, Pennsylvania, United States
Xentria Investigative Site
Prague, Czechia
Start Date
March 1, 2024
Primary Completion Date
January 1, 2029
Completion Date
January 1, 2029
Last Updated
July 9, 2025
NCT04064242
NCT06113991
NCT03599414
NCT01587001
NCT01732211
NCT02188017
Lead Sponsor
Xentria, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions